Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigabatrin with Prednisolone vs Vigabatrin Alone for Infantile Spasms
NCT04302116Recruiting
- Start
- May 2020
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone in infantile epileptic spasms syndrome (IESS) (2 arms). Primary endpoint: Cessation of spasms. Started May 2020; status: recruiting.
02
Drugs
prednisolone
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT04302116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302116.